Literature DB >> 16881132

Is the Jadad score the proper evaluation of trials?

Vance W Berger.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16881132

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  23 in total

1.  Conflicts of Interest, Selective Inertia, and Research Malpractice in Randomized Clinical Trials: An Unholy Trinity.

Authors:  Vance W Berger
Journal:  Sci Eng Ethics       Date:  2014-08-24       Impact factor: 3.525

2.  Trial quality checklists: on the need to multiply (not add) scores.

Authors:  Kaitlin E Palys; Vance W Berger; Sunny Alperson
Journal:  Clin Oral Investig       Date:  2013-06-22       Impact factor: 3.573

3.  CORR Insights ®: Have levels of evidence improved the quality of orthopaedic research?

Authors:  Vance W Berger
Journal:  Clin Orthop Relat Res       Date:  2013-08-01       Impact factor: 4.176

4.  Opposing systematic reviews: the effects of two quality rating instruments on evidence regarding t'ai chi and bone mineral density in postmenopausal women.

Authors:  Sunny Y Alperson; Vance W Berger
Journal:  J Altern Complement Med       Date:  2011-05-06       Impact factor: 2.579

5.  A note on the evaluation of BoNTA trial quality.

Authors:  Vance W Berger; Diana Knoll
Journal:  Inflammopharmacology       Date:  2011-08-30       Impact factor: 4.473

6.  Deep brain stimulation for obsessive-compulsive disorder and treatment-resistant depression: systematic review.

Authors:  Shaheen E Lakhan; Enoch Callaway
Journal:  BMC Res Notes       Date:  2010-03-04

7.  Quality of research: Improper evaluation of the quality of trials of retention rates.

Authors:  C E Jones; V W Berger
Journal:  Br Dent J       Date:  2019-01-25       Impact factor: 1.626

8.  A note on the jadad score as an efficient tool for measuring trial quality.

Authors:  Kaitlin E Palys; Vance W Berger
Journal:  J Gastrointest Surg       Date:  2012-12-12       Impact factor: 3.452

Review 9.  Hibiscus sabdariffa L. in the treatment of hypertension and hyperlipidemia: a comprehensive review of animal and human studies.

Authors:  Allison L Hopkins; Marnie G Lamm; Janet L Funk; Cheryl Ritenbaugh
Journal:  Fitoterapia       Date:  2013-01-17       Impact factor: 2.882

10.  A meta-analysis to determine the effect of pharmacological and non-pharmacological treatments on fibromyalgia symptoms comprising OMERACT-10 response criteria.

Authors:  Despoina Papadopoulou; Argyro Fassoulaki; Christos Tsoulas; Ioanna Siafaka; Athina Vadalouca
Journal:  Clin Rheumatol       Date:  2015-12-17       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.